Cardiovascular Risk and Health Literacy Among Men with Prostate Cancer
Studying Heart Health and Knowledge in Men with Prostate Cancer
Suparna C. Clasen, MD, MSCE
Primary Investigator
Jordan Holmes
Primary Investigator
Brief description of study
Detailed description of study
This is a prospective cohort study designed to evaluate the cardiovascular health literacy, cardiovascular risk, and cardiovascular preventive care of men receiving hormonal therapy as part of definitive treatment for prostate cancer.
The study is designed to oversample AA men to allow comparisons between White and AA patients from Indiana University Simon Comprehensive Cancer Center, Indiana University Health Schwarz Cancer Center, Indiana University West Hospital, and Eskenazi Health.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Non-metastatic prostate cancer
-
Age: 18 years - 100 years
-
Gender: Male
• Male
• Age ≥18 years old at time of consent.
• African American or White
• Written informed consent and HIPAA authorization for release of personal health
information
• Histologically-confirmed, non-metastatic prostate cancer
• Patients who received external beam radiation treatment and androgen deprivation
therapy (total ADT duration > 3 months) for curative intent treatment starting ADT at
least 12 months ago
• Patients currently on or planned for treatment with ADT plus androgen pathway inhibitor
(abiraterone, enzalutamide, apalutamide, darolutamide) are allowed
• Ability to read and write in English
• No mental disability which would preclude completion of questionnaires
• Inability to provide informed consent.
• Serious medical or psychiatric illness likely to interfere with participation in this study.
• Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for
a minimum of 3 years.
• Previous treatment with ADT outside of the index prostate cancer
This study investigates cardiovascular health literacy and risk among men with prostate cancer. The purpose is to compare these factors between African American and White men who are receiving or have completed androgen deprivation therapy, which is a treatment that reduces male hormones to slow cancer growth. The study also explores how different factors like clinical history and socioeconomic status might predict cardiovascular health literacy.
Participants will be part of a cohort study, which means they will be followed over time to observe outcomes. They will receive questionnaires to assess their understanding of cardiovascular health and their risk. The study aims to include more African American men to make accurate comparisons with White men.
- Who can participate: Men aged 18 and older, who are African American or White, with non-metastatic prostate cancer, and have received specific prostate cancer treatments, can participate. They must be able to read and write in English and provide informed consent.
- Study details: Participants will fill out surveys about their heart health knowledge and risks. The study includes men who have received androgen deprivation therapy, a hormonal treatment for prostate cancer. Participation involves comparing health knowledge between different groups.
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
